Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JJH201601 liposome in advanced pancreatic, biliary tract, and hepatocellular carcinoma
ChiCTR2500111729Phase 2Recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Nov 2025
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of JJH201601 in pancreatic adenocarcinoma (PDAC), biliary cancer and hepatocellular carcinoma (HCC), sponsored by Jiangsu Provincial People's Hospital. Primary endpoint: Objective Response Rate. Started Nov 2025; status: recruiting.
02
Drugs
JJH201601
03
Conditions
pancreatic adenocarcinoma (PDAC)biliary cancerhepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on ChiCTR2500111729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500111729.